| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.07 |